Aker BioMarine Company Overview and Financials

Aker BioMarine is a Norwegian company that specializes in the production of krill-based products. They are a leading player in the global market for krill oil and other krill-derived ingredients.

The company was founded in 2005 by Henrik Ebbeskog and is headquartered in Oslo, Norway. Aker BioMarine's flagship product is krill oil, which is extracted from Antarctic krill and is rich in omega-3 fatty acids.

Aker BioMarine's products are used in a variety of applications, including dietary supplements, functional foods, and pharmaceuticals. Their krill oil is considered a high-quality ingredient due to its purity and sustainability.

Aker BioMarine's business operations are built on a strong foundation of sustainability and innovation. The company has implemented a robust supply chain management system to ensure the quality and safety of its krill oil products.

Aker BioMarine's krill fishing vessels are equipped with state-of-the-art technology to minimize bycatch and protect the marine ecosystem. This commitment to sustainability has earned the company certifications such as the MSC (Marine Stewardship Council) standard.

The company's operations are also guided by a strong focus on innovation, with a research and development team working to improve the efficiency and effectiveness of its harvesting and processing methods.

For your interest: Djsi Dow Jones Sustainability Index

Sales by Geography is a crucial aspect of Aker BioMarine ASA's business operations. The company has a significant presence in various regions around the world.

The Americas region has been a consistent revenue generator for the company, with sales reaching $147M in 2020 and $162M in 2023. In contrast, the Asia Pacific region has experienced fluctuations in sales, with a high of $102M in 2023 and a low of $37.2M in 2024.

The EMEA (Europe, Middle East, and Africa) region has also seen a decline in sales, from $54.01M in 2021 to $15.9M in 2024. Norway, a key market for Aker BioMarine ASA, has experienced a significant decline in sales, from $33.6M in 2023 to $5.1M in 2024.

Here is a breakdown of sales by geography for Aker BioMarine ASA:

Aker BioMarine has a unique microalgae strain, Schizochytrium sp., used in their FloraMarine product, which naturally has a high DHA content.

This strain requires minimal processing, unlike standard fish and algae oils that need to be concentrated and altered.

The company has invested in a manufacturing facility in Texas, which came online in 2023, allowing them to control the production process and introduce new ingredients to market.

With this facility, Aker BioMarine can purify raw materials from their algae oil suppliers, giving them a competitive advantage.

Their facility is housed in a revamped food processing plant, showcasing their adaptability and ability to repurpose existing infrastructure.

Aker BioMarine's leadership position and industry know-how have given them the confidence to venture into algae oil production.

Their flagship ingredient, krill oil, has seen 40% growth last year, but they're now focusing on expanding their algae oil business.

Aker BioMarine has a strong leadership team in place. Matts Eirik Johansen serves as the CEO, bringing 49 years of experience to the role.

The Executive Committee at Aker BioMarine ASA is responsible for overseeing the company's operations. Katrine Mourud Klaveness has been the Director of Finance/CFO since July 31, 2018.

Christopher Robin Vinter is the Investor Relations Contact, joining the team on May 31, 2023. Marte Dalsegg and Hege Spaun are both Human Resources Officers, although their exact start dates are not specified.

The Board of Directors at Aker BioMarine ASA is comprised of several experienced members. Ola Snøve serves as the Chairman, having held the position since December 31, 2013.

Here is an overview of the Board of Directors:

The Board of Directors at Aker BioMarine ASA has a good balance of experience and age, with members ranging from 36 to 65 years old.

Aker BioMarine is a Norwegian company founded in 2005.

Their headquarters are located in Oslo, Norway.

Aker BioMarine is a subsidiary of Aker ASA, a Norwegian conglomerate with a diverse range of businesses.

Asa is a company that was founded in 2007. It is a leading provider of digital solutions and services.

Asa's headquarters is located in Oslo, Norway. The company has a strong presence in the European market.

Readers also liked: Torghatten ASA

Asa's main focus is on delivering innovative digital solutions to its clients. This includes developing software and providing IT services.

Asa's team consists of experienced professionals with a deep understanding of the digital landscape. This expertise enables the company to deliver high-quality solutions to its clients.

Asa has a strong track record of delivering successful projects on time and within budget. This is a testament to the company's commitment to excellence and customer satisfaction.

For more insights, see: Odoo Clients

Aker BioMarine is building a protein factory in Norway, specifically in Ski, at a location called Drømtorp. The factory will convert krill into protein.

The estimated cost of building the factory is over 100 million kroner, with a government grant of 21.5 million kroner to help make the project a reality. The factory is expected to be completed by the end of 2022.

Aker BioMarine is a company that was established in 2006 in Norway.

Intriguing read: Norway Oslo Currency

Aker BioMarine's financials are an important aspect of understanding the company's performance. The company's stock, AKBM, is listed on the Stock Market under the Equities section.

Aker BioMarine ASA is the parent company behind AKBM stock, and its financials are a key indicator of the company's overall health.

The company's income statement and estimates are publicly available, providing valuable insights into its financial performance.

Here's a breakdown of the company's financials:

By examining Aker BioMarine's financials, investors and stakeholders can gain a better understanding of the company's performance and make informed decisions.

Aker BioMarine has made significant strides in acquisitions and expansion. The company's Feed Ingredients segment was acquired by American Industrial Partners, a global industrials investor, in July 2024.

The acquisition positions Aker BioMarine to accelerate its growth trajectory and advance the aquaculture, animal health, and sustainability benefits of krill globally. This partnership also brings AIP's maritime expertise and growing aquaculture presence to the table.

Aker BioMarine has also expanded its intellectual property in the krill space, acquiring krill-related patents, pre-clinical and clinical data, and processing equipment from Acasti Pharma Inc. This consolidation of IP will help the company solidify its position in the market.

American Industrial Partners has acquired an ownership position in Aker BioMarine's Feed Ingredients segment.

The Company, Aker BioMarine's Feed Ingredients, will be held by a newly established company, Aker BioMarine Antarctic Holding II AS.

This company will be owned 60% by American Industrial Partners and 40% by Aker ASA, via its wholly owned subsidiary Aker Capital AS.

Aker BioMarine's Feed Ingredients is the world's only industrial-scale krill harvester.

Krill is a highly valuable ingredient in aquaculture feed due to its nutrient-dense properties.

The Company's fishing operations are comprised of three purpose-built Antarctic harvesting and processing vessels, one support vessel, and its shoreside operations are in Montevideo, Uruguay.

The Company employs around 450 employees and crew members.

The acquisition positions Aker BioMarine's Feed Ingredients to accelerate its growth trajectory, leveraging American Industrial Partners' maritime expertise and growing aquaculture presence.

Krill is a powerfully evolving niche market with compelling and sustainable growth opportunities.

American Industrial Partners is wholly committed to a close collaboration with Aker BioMarine's Feed Ingredients, its management team, and Aker ASA to help the Company achieve its great potential.

If this caught your attention, see: Is Bank of China State Owned

Kilyos Nutrition has partnered with Aker BioMarine to introduce its Superba Krill oil ingredient to key supplement brands in Brazil.

This strategic move is a significant expansion for Kilyos Nutrition in the Brazilian market.

Aker BioMarine is a Norwegian fishery and biotech company that specializes in krill oil production.

The partnership will allow Kilyos Nutrition to tap into the growing demand for krill oil supplements in Brazil.

Krill oil is a rich source of omega-3 fatty acids, which are essential for heart health and brain function.

The introduction of Superba Krill oil to the Brazilian market is expected to be a game-changer for the supplement industry.

Kilyos Nutrition is well-positioned to capitalize on this opportunity, given its expertise in the nutrition sector.

The partnership between Kilyos Nutrition and Aker BioMarine is a win-win for both companies, with Aker BioMarine gaining access to new markets and Kilyos Nutrition expanding its product offerings.

The Brazilian market is a lucrative one, with a large and growing population in need of healthy nutrition options.

Kilyos Nutrition's decision to partner with Aker BioMarine is a testament to the company's commitment to innovation and growth.

You might like: Draftkings Big Win

Aker BioMarine ASA has made significant strides in consolidating its intellectual property in the krill space. The company acquired krill-related patents from Acasti Pharma Inc.

Aker BioMarine also gained pre-clinical and clinical data from the acquisition. This valuable information will undoubtedly aid the company in its future research and development endeavors.

The acquisition also included processing equipment, further solidifying Aker BioMarine's position in the krill industry.

Aker BioMarine is a company with a rich history. It was established as an independent company in 2006, building on the Aker Group's many years of experience with deep-sea fishing.

The company's early business activities were previously organized under Aker Seafoods Holding, a 100% subsidiary of Aker ASA. In 2003, Aker began harvesting and processing Antarctic krill. Traditionally, it was difficult to harvest krill in a commercially viable and environmentally sustainable way. Aker claims to have solved this problem through its proprietary Aker Eco-Harvesting technology.

Aker BioMarine was listed on the Oslo Børs on July 6, 2020.

Here are some key events in Aker BioMarine's history:

In 2024, Aker BioMarine sold its Feed Ingredients business to American Industrial Partners and Aker Capital for 6.3 billion kroner.